Temporal trends and predictors of pelvic lymph node dissection in open or minimally invasive radical prostatectomy

Pelvic lymph node dissection (PLND) is an important component of prostate cancer staging and treatment, especially for surgical patients who have high‐risk tumor features. It is not clear how the shift from open radical prostatectomy (ORP) to minimally invasive radical prostatectomy (MIRP) has affected the use of PLND. The objectives of this study were to identify predictors of PLND and to assess the impact of surgical technique in a contemporary, population‐based cohort.

[1]  W. Lowrance,et al.  Comparative effectiveness of prostate cancer surgical treatments: a population based analysis of postoperative outcomes. , 2010, The Journal of urology.

[2]  Matthew R Cooperberg,et al.  Time trends and local variation in primary treatment of localized prostate cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  W. Lowrance,et al.  Minimally invasive vs open radical prostatectomy. , 2010, JAMA.

[4]  J. Mohler.  The 2010 NCCN clinical practice guidelines in oncology on prostate cancer. , 2010, Journal of the National Comprehensive Cancer Network : JNCCN.

[5]  M. Cooperberg,et al.  Adequacy of lymphadenectomy among men undergoing robot‐assisted laparoscopic radical prostatectomy , 2010, BJU international.

[6]  J. Mulhall,et al.  An analysis of sexual health information on radical prostatectomy websites , 2010, BJU international.

[7]  S. Lipsitz,et al.  Comparative effectiveness of minimally invasive vs open radical prostatectomy. , 2009, JAMA.

[8]  Peter C Albertsen,et al.  Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005. , 2009, Journal of the National Cancer Institute.

[9]  J. Renzulli,et al.  The impact of robotic surgery on pelvic lymph node dissection during radical prostatectomy for localized prostate cancer: the Brown University early robotic experience. , 2009, The Canadian journal of urology.

[10]  A. Shalhav,et al.  Pelvic lymphadenectomy during robot-assisted radical prostatectomy: Assessing nodal yield, perioperative outcomes, and complications. , 2009, Urology.

[11]  F. Montorsi,et al.  Pelvic lymph node dissection in prostate cancer. , 2009, European urology.

[12]  K. Touijer.  Editorial comment on: Robotic-assisted laparoscopic extended pelvic lymph node dissection for prostate cancer: surgical technique and experience with the first 99 cases. , 2009, European urology.

[13]  D. Schmid,et al.  Robotic-assisted laparoscopic extended pelvic lymph node dissection for prostate cancer: surgical technique and experience with the first 99 cases. , 2009, European urology.

[14]  A. Mottrie.  Editorial comment on: Robotic-assisted laparoscopic extended pelvic lymph node dissection for prostate cancer: surgical technique and experience with the first 99 cases. , 2009, European urology.

[15]  U. Capitanio,et al.  Impact of surgical volume on the rate of lymph node metastases in patients undergoing radical prostatectomy and extended pelvic lymph node dissection for clinically localized prostate cancer. , 2008, European urology.

[16]  S. Lipsitz,et al.  Variations in surgeon volume and use of pelvic lymph node dissection with open and minimally invasive radical prostatectomy. , 2008, Urology.

[17]  M. Kattan,et al.  Surgeon experience is strongly associated with biochemical recurrence after radical prostatectomy for all preoperative risk categories. , 2008, The Journal of urology.

[18]  M. Kattan,et al.  Effects of pathologic stage on the learning curve for radical prostatectomy: evidence that recurrence in organ-confined cancer is largely related to inadequate surgical technique. , 2008, European urology.

[19]  P. Scardino,et al.  Secondary therapy, metastatic progression, and cancer-specific mortality in men with clinically high-risk prostate cancer treated with radical prostatectomy. , 2008, European urology.

[20]  A. Moinzadeh,et al.  Lymphadenectomy in minimally invasive urologic oncology , 2008, Current opinion in urology.

[21]  M. Kattan,et al.  The surgical learning curve for prostate cancer control after radical prostatectomy. , 2007, Journal of the National Cancer Institute.

[22]  A. D'Amico,et al.  Guideline for the management of clinically localized prostate cancer: 2007 update. , 2007, The Journal of urology.

[23]  A. Shalhav,et al.  Robotic radical prostatectomy learning curve of a fellowship-trained laparoscopic surgeon. , 2007, Journal of endourology.

[24]  P. Scardino,et al.  Long-term outcome following radical prostatectomy in men with clinical stage T3 prostate cancer. , 2006, The Journal of urology.

[25]  E. Castle,et al.  Prospective evaluation of concomitant lymphadenectomy in robot-assisted radical prostatectomy: preliminary analysis of outcomes. , 2006, Journal of endourology.

[26]  P. Scardino,et al.  The association between total and positive lymph node counts, and disease progression in clinically localized prostate cancer. , 2006, The Journal of urology.

[27]  P. Scardino.  Update: NCCN prostate cancer Clinical Practice Guidelines. , 2005, Journal of the National Comprehensive Cancer Network : JNCCN.

[28]  Jie Cai,et al.  Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results. , 2004, The Journal of urology.

[29]  Victor Reuter,et al.  A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer. , 2003, The Journal of urology.

[30]  Steven Piantadosi,et al.  Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. , 2003, The Journal of urology.

[31]  E. Guadagnoli,et al.  Patient Demographic and Socioeconomic Characteristics in the SEER-Medicare Database: Applications and Limitations , 2002, Medical care.

[32]  Deborah Schrag,et al.  Overview of the SEER-Medicare Data: Content, Research Applications, and Generalizability to the United States Elderly Population , 2002, Medical care.

[33]  Pierre I Karakiewicz,et al.  International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  M. Kattan,et al.  A validation of two preoperative nomograms predicting recurrence following radical prostatectomy in a cohort of European men. , 2002, Urologic oncology.

[35]  A W Partin,et al.  Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. , 2002, Urology.

[36]  A. Partin,et al.  Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. , 2001, The Urologic clinics of North America.

[37]  G Vallancien,et al.  Robotic assisted, laparoscopic pelvic lymph node dissection in humans. , 2001, The Journal of urology.

[38]  B. Guillonneau,et al.  Laparoscopic radical prostatectomy: the Montsouris experience. , 2000, The Journal of urology.

[39]  S B Malkowicz,et al.  Biochemical Outcome After Radical Prostatectomy , External Beam Radiation Therapy , or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer , 2000 .

[40]  L. Kessler,et al.  Potential for Cancer Related Health Services Research Using a Linked Medicare‐Tumor Registry Database , 1993, Medical care.

[41]  Catalona Wj.  Pelvic lymphadenectomy is essential to staging accuracy in most patients with stages A-2 and B prostate cancer before radical prostatectomy. , 1983 .

[42]  Alan W Partin,et al.  Validation of the partin nomogram for prostate cancer in a national sample. , 2010, The Journal of urology.

[43]  I. Derweesh,et al.  Lymph node dissection during robot-assisted radical prostatectomy: where do we stand? , 2009, Prostate Cancer and Prostatic Diseases.

[44]  M. Kattan,et al.  How many lymphadenectomies does it take to cure one patient? , 2008, European urology.

[45]  D. Bostwick,et al.  Risk of prostate carcinoma death in patients with lymph node metastasis , 2001, Cancer.

[46]  P. Walsh.  Radical prostatectomy for localized prostate cancer provides durable cancer control with excellent quality of life: a structured debate. , 2000, The Journal of urology.

[47]  W. Catalona.  Pelvic lymphadenectomy is essential to staging accuracy in most patients with stages A-2 and B prostate cancer before radical prostatectomy. , 1983, Seminars in urology.